Wednesday, March 10 is National Women and Girls HIV/AIDS Awareness Day. In recognition, the ETE Dashboard is sharing data on HIV prevention, diagnosis, and care for women in New York State. 

Data reveals sex-based disparities in PrEP access, as well as persistent racial and age-based disparities in HIV diagnosis and treatment outcomes.

Women  make up 1 in 5 new HIV diagnoses in New York State , but only 8.6% of New Yorkers on PrEP are women. [i] Since 2014, PrEP use in NYS has increased steadily, but uptake among women continues to lag far behind.  In 2019, the majority of female New Yorkers with a PrEP prescription were Medicaid recipients (59% Medicaid, 41% non-Medicaid). Conversely, the majority of male New Yorkers with a PrEP prescription were not Medicaid recipients (20% Medicaid, 80% non-Medicaid).

Women of color are disproportionately impacted by HIV, with Black and Hispanic women accounting for 85% of all new HIV diagnoses among women in New York State.  

Despite making up the majority of new diagnoses, Black and Hispanic women are less likely to achieve viral suppression within 3 months of diagnosis than white women.

Transgender women make up 14% of all new HIV diagnoses among women in NYC. The majority of these diagnoses — 61% — occur among women under 30. Learn more about how HIV affects transgender women in NYC in the 2020 HIV Epidemiology Program report.

To explore these data further, visit our PrEP use and New Diagnoses and Linkage data visualization pages, where you can filter results by sex at birth (New York State) or gender (New York City) using the menu drop down features.

[i] Data sources: New York State HIV Surveillance System, 2020. IDV® (Integrated Dataverse) from Symphony Health and the NYS Medicaid Data Warehouse (MDW)